Jake Fillery is an Evergreen Editor for GameRant who has been writing lists, guides, and reviews since 2022. With thousands of engaging articles and guides, Jake loves conversations surrounding all ...
Dan Raby, the senior digital producer for CBS News Atlanta, has been covering everything happening around Georgia for more than a decade. After months of campaigning, the 2026 primary elections in ...
With an eye on the lucrative U.S. market, Italy’s Angelini Pharma will acquire rare disease specialist Catalyst Pharmaceuticals and its potential blockbuster, Firdapse, for $4.1 billion. Rome-based ...
State-backed CDP Equity to have a stake in combined entity Deal comes after Chiesi's $1.9 billion buyout of U.S. KalVista Angelini aims to create global player in rare disease drugs ROME/MILAN, May 7 ...
Italian drugmaker Angelini Pharma is exploring a potential acquisition of Catalyst Pharmaceuticals Inc. as it looks at deals to expand its footprint globally, people familiar with the matter said.
A chemical leak at a West Virginia plant killed two people and sent 19 others to the hospital, authorities said. The leak occurred at the Catalyst Refiners plant, a silver recovery business in ...
Most of the people injured in a chemical release on Wednesday have been treated and released, Kanawha County officials said. West Virginia Gov. Patrick Morrisey said Wednesday evening that as many as ...
Two people are dead, and another was critically injured after a "chemical release" at a West Virginia silver recovery business that was in the process of closing for good, officials said on Wednesday, ...
Revised terms due to delayed projects, lower profits JMAT plans to return 1 billion stg to shareholders post-sale completion Jefferies analysts note revised terms better than potential deal ...
Aluminum is the third-most abundant element in Earth’s crust, after oxygen and silicon. The metal is low cost and highly recyclable, thus making it attractive for chemists looking for more sustainable ...
RESEARCH TRIANGLE PARK, N.C. & NOTTINGHAM, England--(BUSINESS WIRE)--Worldwide Clinical Trials (“Worldwide” or the “Company”), a global contract research organization (CRO), has completed its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results